| Abbott to Pay $1.67B in Patent Suit
| | J&J emerged victorious in a patent suit claiming that the technology behind Abbott's blockbuster arthritis treatment Humira is too similar in design to J&J's Remicade. The cost to Abbott: $1.67 Billion. |
|
| Industry, Health Agencies Respond to Influenza Pandemic
| | | Following the World Health Organization's declaration last week of an influenza pandemic, vaccine makers in Europe and China as well as world health agencies are stepping up efforts toward rapid development and approval of an effective vaccine. |
|
|
|
|
| WHO Pushes H1N1 Flu to Pandemic State
| | | The Word Health Organization just bumped the H1N1 influenza to pandemic alert phase 6 (the highest alert level), making it the first worldwide pandemic in 41 years. |
|
| GSK Teams with Shenzhen Neptunus for Chinese Vaccines
| | | GlaxoSmithKline is expanding its influenza vaccine efforts through a joint R&D alliance with Shenzhen Neptunus. The goal: to tap the world’s biggest market and attempt to deliver flu shots to more than a billion people. |
|
| Patients Abandon Prescriptions at Pharmacy
| | | A report from Wolters Kluwer Health has found that in 2008 use of brand-name drugs went down while use of generics soared, representing 60 percent of all prescriptions filled in the United States. The rate of prescription abandonments also went up — and the higher the co-pay, the greater the likelihood of abandonment. |
|
